Synthetic Control of Pt···Pt Separation and Photophysics of Binuclear Platinum Complexes by Biwu Ma (1280805)

“…A new series of luminescent μ-pyrazolate-bridged cyclometalated platinum binuclear complexes having the formula <i>C</i>^∧<i>N</i>Pt(μ-<i>pz</i><i>‘</i>)₂Pt<i>C</i>^∧<i>N</i> (<i>C</i>^∧<i>N</i> = 2-(2,4-difluorophenyl)pyridyl, <i>pz</i><i>‘</i> = pyrazolate for <b>1</b>, 3,5-dimethylpyrazolate for <b>2</b>, 3-methyl-5-<i>tert</i>-butylpyrazolate for <b>3</b>, and 3,5-bis(<i>tert</i>-butyl)pyrazolate for <b>4</b>) have been synthesized and characterized. …”

Synthetic Control of Pt···Pt Separation and Photophysics of Binuclear Platinum Complexes by Biwu Ma (1280805)

“…A new series of luminescent μ-pyrazolate-bridged cyclometalated platinum binuclear complexes having the formula <i>C</i>^∧<i>N</i>Pt(μ-<i>pz</i><i>‘</i>)₂Pt<i>C</i>^∧<i>N</i> (<i>C</i>^∧<i>N</i> = 2-(2,4-difluorophenyl)pyridyl, <i>pz</i><i>‘</i> = pyrazolate for <b>1</b>, 3,5-dimethylpyrazolate for <b>2</b>, 3-methyl-5-<i>tert</i>-butylpyrazolate for <b>3</b>, and 3,5-bis(<i>tert</i>-butyl)pyrazolate for <b>4</b>) have been synthesized and characterized. …”

Synthetic Control of Pt···Pt Separation and Photophysics of Binuclear Platinum Complexes by Biwu Ma (1280805)

“…A new series of luminescent μ-pyrazolate-bridged cyclometalated platinum binuclear complexes having the formula <i>C</i>^∧<i>N</i>Pt(μ-<i>pz</i><i>‘</i>)₂Pt<i>C</i>^∧<i>N</i> (<i>C</i>^∧<i>N</i> = 2-(2,4-difluorophenyl)pyridyl, <i>pz</i><i>‘</i> = pyrazolate for <b>1</b>, 3,5-dimethylpyrazolate for <b>2</b>, 3-methyl-5-<i>tert</i>-butylpyrazolate for <b>3</b>, and 3,5-bis(<i>tert</i>-butyl)pyrazolate for <b>4</b>) have been synthesized and characterized. …”

Synthetic Control of Pt···Pt Separation and Photophysics of Binuclear Platinum Complexes by Biwu Ma (1280805)

“…A new series of luminescent μ-pyrazolate-bridged cyclometalated platinum binuclear complexes having the formula <i>C</i>^∧<i>N</i>Pt(μ-<i>pz</i><i>‘</i>)₂Pt<i>C</i>^∧<i>N</i> (<i>C</i>^∧<i>N</i> = 2-(2,4-difluorophenyl)pyridyl, <i>pz</i><i>‘</i> = pyrazolate for <b>1</b>, 3,5-dimethylpyrazolate for <b>2</b>, 3-methyl-5-<i>tert</i>-butylpyrazolate for <b>3</b>, and 3,5-bis(<i>tert</i>-butyl)pyrazolate for <b>4</b>) have been synthesized and characterized. …”

Synthetic Control of Pt···Pt Separation and Photophysics of Binuclear Platinum Complexes by Biwu Ma (1280805)

“…A new series of luminescent μ-pyrazolate-bridged cyclometalated platinum binuclear complexes having the formula <i>C</i>^∧<i>N</i>Pt(μ-<i>pz</i><i>‘</i>)₂Pt<i>C</i>^∧<i>N</i> (<i>C</i>^∧<i>N</i> = 2-(2,4-difluorophenyl)pyridyl, <i>pz</i><i>‘</i> = pyrazolate for <b>1</b>, 3,5-dimethylpyrazolate for <b>2</b>, 3-methyl-5-<i>tert</i>-butylpyrazolate for <b>3</b>, and 3,5-bis(<i>tert</i>-butyl)pyrazolate for <b>4</b>) have been synthesized and characterized. …”

Similar Trends in Serum VEGF-D Levels and Kidney Angiomyolipoma Responses with Longer Duration Sirolimus Treatment in Adults with Tuberous Sclerosis by Izabela A. Malinowska (378985)

“…<div><p>Context</p><p>We have previously shown that serum VEGF-D is elevated at baseline, correlates with kidney angiomyolipoma size at baseline and 12 months, and decreases with sirolimus treatment in adults with tuberous sclerosis complex (TSC). …”

Comparative death probabilities of tumor-bearing mice across weeks of assessment. by Robert Botelho (20308297)

Cu(HCO₂)₂(pym) (pym = pyrimidine):  Low-Dimensional Magnetic Behavior and Long-Range Ordering in a Quantum-Spin Lattice by J. L. Manson (2472649)

“…The compound crystallizes in the monoclinic space group <i>C</i>2/<i>c</i> with <i>a</i> = 14.4639(8) Å, <i>b</i> = 7.7209(4) Å, <i>c</i> = 8.5172(5) Å, β = 126.076(2)°, and <i>V</i> = 768.76(7) ų. …”

DataSheet2_Efficacy and safety of fenofibrate add-on therapy in patients with primary biliary cholangitis refractory to ursodeoxycholic acid: A retrospective study and updated meta... by Xuan Guoyun (13521745)

“…Biochemical and clinical indicator changes in UDCA-refractory PBC patients receiving combination therapy were analyzed by Revman 5.42. Then, we explored the influence of fenofibrate dose and the effectiveness and safety of long-term application by retrospective cohort study.…”

DataSheet1_Efficacy and safety of fenofibrate add-on therapy in patients with primary biliary cholangitis refractory to ursodeoxycholic acid: A retrospective study and updated meta... by Xuan Guoyun (13521745)

“…Biochemical and clinical indicator changes in UDCA-refractory PBC patients receiving combination therapy were analyzed by Revman 5.42. Then, we explored the influence of fenofibrate dose and the effectiveness and safety of long-term application by retrospective cohort study.…”

Fig 3 - by Niu Yayi (10834325)

The values for <i>k</i>_cat and <i>K</i>_M are sourced from [19]. by J. Roadnight Sheehan (20141887)

Table_1_TIPRL, a Novel Tumor Suppressor, Suppresses Cell Migration, and Invasion Through Regulating AMPK/mTOR Signaling Pathway in Gastric Cancer.DOCX by Meng Luan (528208)

“…Moreover, TIPRL was identified as a direct target of miR-216a-5p and miR-383-5p. …”

Table_1_Coenzyme Q10 Reduces Infarct Size in Animal Models of Myocardial Ischemia-Reperfusion Injury: A Meta-Analysis and Summary of Underlying Mechanisms.docx by Kamal Awad (12420565)

Structure–Activity Relationship of Peptide-Conjugated Chloramphenicol for Inhibiting Escherichia coli by Jiaqing Wang (1542784)

“…These analogues reveal several trends: (i) except the water-insoluble analogues, the attachment of peptides to CLsu enhances the efficacy of the prodrugs; (ii) negative charges, high steric hindrance in the side chains, or a rigid diester decreases the activities of prodrugs in comparison to CLsuGG; (iii) dipeptides apparently increase the efficacy of the prodrugs most effectively; and so forth. …”

S1 File - by Esra’a Samara (16877471)

“…Hyperpolypharmacy (> 10 drugs) [aOR = 4.1, 95%CI: 1.6–10.7], polypharmacy [aOR = 2.8, 95%CI: 1.4–5.4], and Diabetes [aOR = 3.5, 95%CI: 2.0–6.0] are the main associated factors of PIM.…”

Data_Sheet_1_State-Dependent Entrainment of Prefrontal Cortex Local Field Potential Activity Following Patterned Stimulation of the Cerebellar Vermis.PDF by Stéfanie A. Tremblay (7554821)

“…Single-pulses resulted in increases in oscillatory power in the delta and theta bands for the cerebellum, and in frequencies up to 80 Hz in cortical sites. 1 Hz stimulation induced a decrease in 0–30 Hz activity and increased activity in the 30–200 Hz range, in the right FrA. 5 Hz stimulation reduced power in high frequencies in Stage 1 and induced mixed effects during Stage 2.25 Hz stimulation increased cortical power at low frequencies during Stage 2, and increased power in higher frequency bands during Stage 1. …”

Fig 1 - by Sławomir Grzegorczyn (12035398)

Image_3_Cell Death Triggered by the Autophagy Inhibitory Drug 3-Methyladenine in Growing Conditions Proceeds With DNA Damage.jpeg by Javier Chicote (9521855)

“…Among them, 3-methyladenine, SBI-0206965, Chloroquine, and Bafilomycin A₁ triggered BAX- and/or BAK-dependent cytotoxicity and caspase activation. 3-methyladenine was the only compound to induce a consistent and abrupt decrease in cell viability across a series of ontologically unrelated human cell lines. 3-methyladenine-induced cytotoxicity was not driven by the inhibition of the AKT/mTOR axis. …”

Image_4_Cell Death Triggered by the Autophagy Inhibitory Drug 3-Methyladenine in Growing Conditions Proceeds With DNA Damage.jpeg by Javier Chicote (9521855)

“…Among them, 3-methyladenine, SBI-0206965, Chloroquine, and Bafilomycin A₁ triggered BAX- and/or BAK-dependent cytotoxicity and caspase activation. 3-methyladenine was the only compound to induce a consistent and abrupt decrease in cell viability across a series of ontologically unrelated human cell lines. 3-methyladenine-induced cytotoxicity was not driven by the inhibition of the AKT/mTOR axis. …”